BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21713322)

  • 1. Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer.
    Menapace LA; Peterson DR; Berry A; Sousou T; Khorana AA
    Thromb Haemost; 2011 Aug; 106(2):371-8. PubMed ID: 21713322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.
    Connolly GC; Menapace L; Safadjou S; Francis CW; Khorana AA
    Clin Lung Cancer; 2013 Nov; 14(6):713-8. PubMed ID: 23891560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients.
    den Exter PL; Hooijer J; Dekkers OM; Huisman MV
    J Clin Oncol; 2011 Jun; 29(17):2405-9. PubMed ID: 21555690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
    Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
    Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
    Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
    J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of illness in venous thromboembolism in critical care: a multicenter observational study.
    Patel R; Cook DJ; Meade MO; Griffith LE; Mehta G; Rocker GM; Marshall JC; Hodder R; Martin CM; Heyland DK; Peters S; Muscedere J; Soth M; Campbell N; Guyatt GH; ;
    J Crit Care; 2005 Dec; 20(4):341-7. PubMed ID: 16310605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental venous thromboembolism in cancer patients: prevalence and consequence.
    Douma RA; Kok MG; Verberne LM; Kamphuisen PW; Büller HR
    Thromb Res; 2010 Jun; 125(6):e306-9. PubMed ID: 20223502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
    Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
    Kolomansky A; Hoffman R; Sarig G; Brenner B; Haim N
    Isr Med Assoc J; 2006 Dec; 8(12):848-52. PubMed ID: 17214102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy.
    Secin FP; Jiborn T; Bjartell AS; Fournier G; Salomon L; Abbou CC; Haber GP; Gill IS; Crocitto LE; Nelson RA; Cansino Alcaide JR; Martínez-Piñeiro L; Cohen MS; Tuerk I; Schulman C; Gianduzzo T; Eden C; Baumgartner R; Smith JA; Entezari K; van Velthoven R; Janetschek G; Serio AM; Vickers AJ; Touijer K; Guillonneau B
    Eur Urol; 2008 Jan; 53(1):134-45. PubMed ID: 17597288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents.
    Liperoti R; Pedone C; Lapane KL; Mor V; Bernabei R; Gambassi G
    Arch Intern Med; 2005 Dec 12-26; 165(22):2677-82. PubMed ID: 16344428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
    Chew HK; Wun T; Harvey DJ; Zhou H; White RH
    J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival.
    Abu-Rustum NR; Richard S; Wilton A; Lev G; Sonoda Y; Hensley ML; Gemignani M; Barakat RR; Chi DS
    Gynecol Oncol; 2005 Nov; 99(2):320-6. PubMed ID: 16061278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism in cancer patients in Christchurch, 1995-1999.
    Joung S; Robinson B
    N Z Med J; 2002 Jun; 115(1155):257-60. PubMed ID: 12117159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study.
    Severinsen MT; Johnsen SP; Tjønneland A; Overvad K; Dethlefsen C; Kristensen SR
    Eur J Intern Med; 2010 Aug; 21(4):268-72. PubMed ID: 20603033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.
    Eriksson H; Lundström T; Wåhlander K; Clason SB; Schulman S;
    Thromb Haemost; 2005 Sep; 94(3):522-7. PubMed ID: 16268466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism in passengers following a 12-h flight: a case-control study.
    Paganin F; Bourdé A; Yvin JL; Génin R; Guijarro JL; Bourdin A; Lassalle C
    Aviat Space Environ Med; 2003 Dec; 74(12):1277-80. PubMed ID: 14692472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.